High Drug Deductibles Flagged In Exchange Plan Analysis
This article was originally published in The Pink Sheet Daily
A Milliman study commissioned by PhRMA prompts concerns that members in nearly half of silver plans offered through state exchanges will have to spend thousands of dollars out of pocket before drug coverage begins.
You may also be interested in...
Temporary policy may open door to longer term change as Medicare allows reimbursement of at-home administration of non-hospital drugs covered by Part B under a recently-released regulation aiding at encouraging telehealth during the coronavirus outbreak.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.
Guidelines for US health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.